Time from referral to randomization is best understood as a series of pathway intervals. Measuring each interval helps sites identify operational waiting time, clarify ownership, and review escalation without treating elapsed time as proof of dropout or a guarantee of enrollment improvement. Appropriate goals depend on study requirements, staffing, contact permissions, communication channel, candidate availability, protocol complexity, and site-approved escalation rules.
Define the start and end event for each interval, assign an owner, and compare current observations with the site's own study-specific goal. The framework below provides measurement categories rather than universal response-time benchmarks.
Interval
Referral received to first documented action
Planning Goal
Site-defined interval
Primary Driver
Ownership, staffing, permissions, and channel
Interval
First action to successful contact
Planning Goal
Site-defined interval
Primary Driver
Permitted follow-up and candidate response
Interval
Successful contact to completed preliminary intake
Planning Goal
Site-defined interval
Primary Driver
Candidate availability and required information
Interval
Preliminary intake to authorized site review
Planning Goal
Site-defined interval
Primary Driver
Handoff standard, workload, and escalation
Interval
Site review to scheduling
Planning Goal
Site-defined interval
Primary Driver
Site process, protocol, and appointment capacity
Interval
Scheduling to attended site visit
Planning Goal
Site-defined interval
Primary Driver
Candidate and site availability
Interval
Formal screening and later stages
Planning Goal
Controlled by the research site
Primary Driver
Protocol, clinical findings, consent, and site decisions
Each strategy below addresses a defined operational interval before or around authorized site review. Sites should adapt the approach to protocol requirements, staffing, permissions, candidate needs, and clinical workflows.
Set a site-approved interval from referral receipt to the first documented action, then assign ownership and escalation for records approaching that interval. The appropriate goal depends on study requirements, staffing, contact permissions, communication channel, referral volume, and candidate population.
Queue depth and record age show whether referrals are arriving faster than the assigned team can process them. Reviewing those measures against available staffing and follow-up rules helps the site decide whether ownership, capacity, or escalation needs attention.
When preliminary intake is complete, candidate-reported information should be organized according to the site-approved handoff standard and prepared for authorized site review. Documenting required fields and unresolved questions at that transition helps the site see whether handoff preparation is contributing to elapsed time.
The research site can define an appropriate review interval and escalation path for completed handoffs based on protocol complexity, staffing, workload, and scheduling processes. The site retains clinical interpretation, formal screening, eligibility decisions, medical decisions, informed consent, protocol oversight, investigator responsibility, and randomization decisions.
Where permitted by the site-approved workflow, recording candidate-reported availability and communication preferences before handoff gives authorized site staff relevant scheduling context. Candidate availability can change, so the record supports coordination rather than guaranteeing a direct scheduling step or shorter timeline.
Pathway-interval data also supports coordinator capacity planning. Queue depth, handoff volume, record completeness, and scheduled site activity help leaders compare incoming work with available staffing. Complete records can reduce some administrative reconstruction, but the workload effect depends on protocol complexity, tools, staffing, and implementation.
For guidance on the workflow design behind these intervals, see referral-to-randomization workflow. For intake ownership and documentation, see clinical trial intake. For broader process design, see building a standardized enrollment workflow. For candidate-pathway discontinuation points that sites can investigate, see how patients get lost between referral and randomization.
Common questions about monitoring referral-to-randomization intervals, addressing administrative waiting time, and preserving site clinical authority.
Related Resources
Continue Reading
If elapsed time is difficult to explain across your referral-to-randomization pathway, a structured review can define intervals, identify operational waiting points, and clarify ownership and escalation.